Pericardial Effusion: Clinical Trials

2 trials for Pericardial Effusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Pericardial Effusion: new trials by email Literature Review of Pericardial Effusion trials Research Report on Pericardial Effusion

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer
Bevacizumab - Non-small Cell Lung Cancer, Malignant Pleural Effusion
Phase 2CompletedHaihong Yang, MD, Pricipal investigator222014-01-012019-03-29
Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer
Alimta - Lung Cancer
Phase 2CompletedM.D. Anderson Cancer Center642005-09-012017-02-13

Narrower conditions

Carcinoma, Non-Small-Cell Lung (2)  ·  Pleural Effusion, Malignant (2)  ·  Lung Neoplasms (1)

Broader conditions

Bronchial Neoplasms (2)  ·  Carcinoma, Bronchogenic (2)  ·  Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Lung Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Pleural Diseases (2)  ·  Pleural Effusion (2)  ·  Pleural Neoplasms (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Neoplasms (2)  ·  Thoracic Neoplasms (2)  ·  Lung Neoplasms (1)

Interventions

Bevacizumab (1)  ·  Pemetrexed (1)

Sponsors

Haihong Yang, MD, Pricipal investigator (1)  ·  M.D. Anderson Cancer Center (1)

Countries

China (1)  ·  United States (1)

Top investigators

Haihong Yang, MD (1)  ·  Ralph Zinner, MD (1)